Approval · Notice of Compliance 289 · 2004
BONVIVA: Notice of Compliance 289
Issued March 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 289
- Date
- March 23, 2004
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONVIVA | 02250136 | — |
Medicinal ingredients
- IBANDRONATE SODIUM 2.5 MG per TAB